Suven Pharma Q3FY22 PAT at Rs. 160.06 crore
News

Suven Pharma Q3FY22 PAT at Rs. 160.06 crore

Suven Pharmaceuticals has reported consolidated financial results for the period ended December 31, 2021.

  • By IPP Bureau | February 08, 2022

Financial Results (Q3 FY2022) - QoQ comparison

The company has reported a total income of Rs. 456.2704 crore during the period ended December 31, 2021 as compared to Rs. 306.0294 crore during the period ended September 30, 2021.

The company has posted a net profit of Rs. 160.0690 crore for the period ended December 31, 2021 as against a net profit of Rs. 96.9848 crore for the period ended September 30, 2021.

Financial Results (Q3 FY2022) - YoY comparison

The company has reported a total income of Rs. 456.2704 crore during the period ended December 31, 2021 as compared to Rs.279.7761 crore during the period ended December 31, 2020.

The company has posted a net profit of Rs.160.0690 crore for the period ended December 31, 2021 as against a net profit  of Rs.113.6253 crore for the period ended December 31, 2020.

Financial Results (nine-month ended FY2022) - YoY comparison

The company has reported total income of Rs.1031.8840 crore during the nine-month period ended December 31, 2021 as compared to Rs.761.4925 crore during the nine-month period ended December 31, 2020.

The company has posted a net profit of Rs.362.1369 crore for the nine-month period ended December 31, 2021 as against a net profit of Rs.279.2259 crore for the nine-month period ended December 31, 2020.

Upcoming E-conference

Other Related stories

Startup

Digitization